United States · 
Who invested in Scanogen?
Scanogen's investors include National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Scanogen
Funding summaryUpdated 26 Oct 2026
$2.9Mraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $2.9MSept 2025
- Investors
- 1
The rounds
- Sept 2025
Founders and team
From Scanogen's own website: 3 on the team.
- Adam SteelInterim Chief Operations Officer
- Aylish PtakDirector of Assay Development
- Michael VanSicklerDirector of Engineering
AdvisersRichard Brock
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Scanogen
How much has Scanogen raised?
Scanogen has raised $2.9M across 1 round since 2025.
When did Scanogen last raise?
Scanogen's most recent round was a Grant of $2.9M in Sept 2025.
What was Scanogen's biggest round?
Its most recent round, $2.9M in Sept 2025, is also its largest on record.
Who backed Scanogen first?
Scanogen's first round on record, in Sept 2025, was backed by National Institute of Allergy and Infectious Diseases.
What stage is Scanogen at?
Scanogen's latest named round is a Grant, in Sept 2025.
Where is Scanogen based?
Scanogen is based in the United States.
Companies like Scanogen
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.